Thrombophilias and arteriovenous fistula dysfunction in maintenance hemodialysis

Journal of Thrombosis and Thrombolysis

Volumn 27, Issue 3, 2009, Pages 307-315

  Danis, Ramazan ^a   Ozmen, Sehmus ^a   Akin, Davut ^a   Batun, Sabri ^a   Kahvecioglu, Serdar ^b   Altintas, Abdullah ^a   Yilmaz, Mehmet E ^a   Polat, Adil ^b  

^a DICLE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^b Diyarbakir Devlet Hastanesi   (Turkey)

Author keywords

Hemodialysis; Primary fistula failure; Secondary fistula failure; Thrombophilias

Indexed keywords

ALBUMIN; BLOOD CLOTTING FACTOR;

ADULT; ALBUMIN BLOOD LEVEL; ARTERIOVENOUS FISTULA; ARTICLE; BODY MASS; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC ASSOCIATION; HEMODIALYSIS; HUMAN; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MUTATIONAL ANALYSIS; PRIORITY JOURNAL; SELF REPORT; THROMBOPHILIA; THROMBOSIS; VASCULAR ACCESS;

ADULT; ANTITHROMBIN III; ARTERIOVENOUS SHUNT, SURGICAL; BODY MASS INDEX; FEMALE; GENETIC SCREENING; HUMANS; MALE; MIDDLE AGED; RENAL DIALYSIS; SERUM ALBUMIN; THROMBOPHILIA; THROMBOSIS;

EID: 64749095987     PISSN: 09295305     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11239-008-0216-z     Document Type: Article

References (45)

1. United States Renal Data System (2002) 2002 Annual data report. National Institutes of Health, National Institute of Diabetes and Digestive Diseases, Bethesda
2. Schwab SJ, Harrington JT, Singh A et al (1999) Vascular access for hemodialysis. Kidney Int 55:2078-2090
3. Miller PE, Tolwani A, Luscy CP et al (1999) Predictors of adequacy of arteriovenous fistulas in hemodialysis patients. Kidney Int 56:275-280
4. Hodges TC, Fillinger MF, Zwolak RM et al (1997) Longitudinal comparison of dialysis access methods: Risk factors for failure. J Vasc Surg 26:1009-1019
5. LeSar CJ, Merrick HW, Smith MR (1999) Thrombotic complications resulting from hypercoagulable states in chronic hemodialysis vascular access. J Am Coll Surg 189:73-79
6. Tessitore N, Mansueto G, Bedogna V et al (2003) A prospective controlled trial on effect of percutaneous transluminal angioplasty on functioning arteriovenous fistulae survival. J Am Soc Nephrol 14:1623-1627
7. Bell DD, Rosental JJ (1988) Arteriovenous graft life in chronic haemodialysis. Arch Surg 123:1169-1172
8. Tripodi A, Mannucci PM (2001) Laboratory investigation of thrombophilia. Clin Chem 47:1597-1606
9. Casserly LF, Dember LM (2003) Thrombosis in end-stage renal disease. Semin Dial 16:245-256
10. Paulson WD (2000) Prediction of hemodialysis synthetic graft thrombosis: can we identify factors that impair validity of the dysfunction hypothesis? Am J Kidney Dis 35:973-975
11. Nampoory MR, Das KC, Johny KV et al (2003) Hypercoagulability, a serious problem in patients with ESRD on maintenance hemodialysis, and its correction after kidney transplantation. Am J Kidney Dis 42:797-805
12. O'shea SI, Lawson JH, Reddan D et al (2003) Hypercoagulable states and antithrombotic strategies in recurrent vascular access site thrombosis. J Vasc Surg 38:541-548
13. Fukasawa M, Matsushita K, Kamiyama M et al (2003) The methylentetrahydrofolate reductase C677T point mutation is a risk factor for vascular access thrombosis in hemodialysis patients. Am J Kidney Dis 41:637-642
14. Atac B, Yakupoglu U, Ozbek N et al (2002) Role of genetic mutations in vascular access thrombosis among hemodialysis patients waiting for renal transplantation. Transplant Proc 34:2030-2032
15. Shemin D, Lapane KL, Bausserman L et al (1999) Plasma total homocysteine and hemodialysis access thrombosis: A prospective study. J Am Soc Nephrol 10:1095-1099
16. Knoll GA, Wells PS, Young D et al (2005) Thrombophilia and the risk for hemodialysis vascular access thrombosis. J Am Soc Nephrol 16(4):1108-1114
17. Prakash R, Miller ICC, Suki WN (1995) Anticardiolipin antibody in patients on maintenance hemodialysis and its association with recurrent arteriovenous graft thrombosis. Am J Kidney Dis 26:347-352
18. Palomo I, Pereira J, Alarcon M et al (2002) Vascular access thrombosis is not related to presence of antiphospholipid antibodies in patients on chronic hemodialysis. Nephron 92:957-958
19. Adler S, Szczech L, Qureshi A et al (2001) IgM anticardiolipin antibodies are associated with stenosis of vascular access in hemodialysis patients but do not predict thrombosis. Clin Nephrol 56:428-434
20. Fodinger M, Mannhalter C, Pabinger I et al (1996) Resistance to activated protein C (APC): Mutation at ARG of coagulation factor V and vascular access thrombosis in hemodialysis patients. Nephrol Dial Transplant 11:668-672
21. Manns BJ, Burgess ED, Parsons HG et al (1999) Hyperhomocysteinemia, anticardiolipin antibody status, and risk for vascular access thrombosis in hemodialysis patients. Kidney Int 55:315-320
22. Bertina RM, Rosendaal FR (1998) Venous thrombosis-the interaction of genes and environment. N Engl J Med 338(25):1840-1841
23. Girndt M, Heine GH, Ulrich C, Kohler H, DialGene Consortium (2007) Gene polymorphism association studies in dialysis: Vascular access. Semin Dial 20(1):63-67
24. Gallagher PM, Meleady R, Shields DC et al (1996) Homocysteine and risk of premature coronary heart disease. Evidence for a common gene mutation. Circulation 94:2154-2158
25. Kushiya F, Wada H, Sakakura M et al (2003) Effects of lipid abnormalities on arteriosclerosis and hemostatic markers in patients under hemodialysis. Clin Appl Thromb Hemost 9(3):203-210
26. Sitter T, Schiffl H (1993) Anticardiolipin antibodies in patients on regular haemodialysis: An epiphenomenon. Nephron 64:655-656
27. Lai KN, Yin JA, Yuen PMP et al (1991) Effect of hemodialysis on protein C, protein S, and antithrombin III levels. Am J Kidney Dis 27:38-42
28. Ohira S, Kon T, Imura T (2005) Evaluation of primary failure in native AV-fistulae (early fistula failure). Hemodial Int 10:173-179
29. Feldman HI, Joffe M, Rosas SE et al (2003) Predictors of successful arteriovenous fistula maturation. Am J Kidney Dis 42(5):1000-1012
30. Kats M, Hawxby AM, Barker J et al (2007) Impact of obesity on arteriovenous fistula outcomes in dialysis patients. Kidney Int 71(1):39-43
31. Chuang FR, Chang HW, Lin CL et al (2005) Anticardiolipin antibody and Taiwanese chronic haemodialysis patients with recurrent vascular access thrombosis. Int J Clin Pract 59(7):785-790
32. Kalkanli S, Ayyildiz O, Tiftik N et al (2001) Factor V Leiden mutation in our region. In: XIX. National Gevher Nesibe meeting, congress and workshop of hematology-oncology, Congress Book (Turkish), Nevsehir, Turkey, May 24-26, 106 pp
33. Irdem A, Devecioglu C, Batun S et al (2005) Prevalence of factor V Leiden and prothrombin G20210A gene mutation. Saudi Med J 26(4):580-583
34. Bremer C, Schaefer RM (1997) Heterozygosity for factor V Leiden in a haemodialysis patient with recurrent shunt thrombosis. Nephrol Dial Transplant 12:1775-1776
35. Kim RJ, Becker RC (2003) Association between factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations and events of the arterial circulatory system: A meta-analysis of published studies. Am Heart J 146:948-957
36. Ayyildiz O, Kalkanli S, Batun S et al (2004) Prothrombin G20210A gene mutation with LightCycler polymerase chain reaction in venous thrombosis and healthy population in the southeast of Turkey. Heart Vessels 19(4):164-166
37. Homocysteine Studies Collaboration (2002) Homocysteine and risk of ischemic heart disease and stroke: A meta-analysis. JAMA 288:2015-2022
38. Mallamaci F, Bonanno G, Seminara G et al (2005) Hyperhomocysteinemia and arteriovenous fistula thrombosis in hemodialysis patients. Am J Kidney Dis 45:702-707
39. Serin E, Guclu M, Atac FB et al (2007) Methylenetetrahydrofolate reductase C677T mutation and nonalcoholic fatty liver disease. Dig Dis Sci 52(5):1183-1186
40. Charvat J, Kestlerova M, Jarosova H et al (1994) Relation between the blood coagulation status in hemodialyzed patients and arteriovenous fistula thrombosis-prospective study. Cas Lek Cesk 18;133(8):242-244 [Abstract]
41. Molino D, De Lucia D, Marotta R et al (2005) In uremia, plasma levels of anti-protein C and anti-protein S antibodies are associated with thrombosis. Kidney Int 68(3):1223-1229
42. Windus DW, Jendrisak MD, Delmez JA (1992) Prosthetic fistula survival and complications in hemodialysis patients: Effects of diabetes and age. Am J Kidney Dis 19:448-452
43. Churchill DN, Taylor DW, Cook RJ et al (1992) Canadian hemodialysis morbidity study. Am J Kidney Dis 19(3):214-234
44. Dy GR, Bloom EJ, Ijelu GK et al (1991) Effect of recombinant human erythropoietin on vascular access. ASAIO Trans 37(3):M274-275
45. Dixon BS, Novak L, Fangman J (2002) Hemodialysis vascular access survival:tHe upper arm native arteriovenous fistula. Am J Kidney Dis 39:92-101